Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models – two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers

Bibliography

• Maier C, Baron R, Tolle TR, Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010;12:439-50
   Google Scholar
• Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin 2009;25:1663-76
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009;25:1677-87
   PubMed Web of Science ®Google Scholar
• Binder A, Bruxelle J, Rogers P, Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig 2009;29:393-408
   PubMed Web of Science ®Google Scholar
• Hans G, Sabatowski R, Binder A, Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-305
   PubMed Web of Science ®Google Scholar
• Barbano RL, Herrmann DN, Hart-Gouleau S, Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004;61:914-18
   PubMed Web of Science ®Google Scholar
• Meier T, Wasner G, Faust M, Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003;106:151-8
   PubMed Web of Science ®Google Scholar
• Kern KU, Kohl M, Kiefer RT. Lidocaine patch for therapy of neuropathic and non-neuropathic pain: a clinical case series of 87 patients [in German]. Nervenarzt 2010;81:1490-7
   PubMed Web of Science ®Google Scholar
• Herrmann DN, Barbano RL, Hart-Gouleau S, An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 2005;6:379-84
   PubMed Web of Science ®Google Scholar
• Nalamachu S, Crockett RS, Gammaitoni AR, Gould EM. A comparison of the lidocaine patch 5% vs. naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. Med Genet Med 2006;8:33
   PubMedGoogle Scholar
• Wilhelm IR, Tzabazis A, Likar R, Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anaesthesiol 2010;27:169-73
   PubMed Web of Science ®Google Scholar
• Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases. Curr Med Res Opin 2009;25:2737-43
   PubMed Web of Science ®Google Scholar
• Wasner G, Kleinert A, Binder A, Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005;252:677-86
   PubMed Web of Science ®Google Scholar
• Herrmann DN, Pannoni V, Barbano RL, Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies. Muscle Nerve 2006;33:42-8
   PubMed Web of Science ®Google Scholar
• Lai J, Hunter JC, Porreca F. The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol 2003;13:291-7
   PubMed Web of Science ®Google Scholar
• Baron R. Mechanisms of disease: neuropathic pain – a clinical perspective. Nat Clin Pract Neurol 2006;2:95-106
   PubMedGoogle Scholar
• Campbell BJ, Rowbotham M, Davies PS, Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002;91:1343-50
   PubMed Web of Science ®Google Scholar
• Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998;354:R13-14
   PubMed Web of Science ®Google Scholar
• Voller B, Sycha T, Gustorff B, A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology 2003;61:940-4
   PubMed Web of Science ®Google Scholar
• Wang H, Bolognese J, Calder N, Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. Br J Pain 2008;9:1088-95
   Google Scholar
• Bickel A, Dorfs S, Schmelz M, Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain 1998;76:317-25
   PubMed Web of Science ®Google Scholar
• Sycha T, Gustorff B, Lehr S, A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects. Br J Clin Pharmacol 2003;56:165-72
   PubMed Web of Science ®Google Scholar
• Gustorff B, Hoechtl K, Sycha T, The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers. Anesth Analg 2004;98:401-7
   PubMed Web of Science ®Google Scholar
• Sycha T, Anzenhofer S, Lehr S, Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model. Pain 2005;113:316-22
   PubMed Web of Science ®Google Scholar
• Sycha T, Samal D, Chizh B, A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model. Anesth Analg 2006;102:509-16
   PubMed Web of Science ®Google Scholar
• Electronic Medicines Compendium. Versatis 5% medicated plaster. Summary of product characteristics. Available from: http://emc.medicines.org.uk/medicine/19291/SPC/Versatis+5%25+Medicated+Plaster [Last accessed 5 April 2011]
   Google Scholar
• Bevan S, Szolcsanyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 1990;11:330-3
   PubMed Web of Science ®Google Scholar
• LaMotte RH, Lundberg LE, Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992;448:749-64
   PubMed Web of Science ®Google Scholar
• Torebjork HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 1992;448:765-80
   PubMed Web of Science ®Google Scholar
• Shenker NG, Haigh RC, Mapp PI, Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology (Oxford) 2008;47:1417-21
   PubMed Web of Science ®Google Scholar
• Gustorff B, Anzenhofer S, Sycha T, The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting. Anesth Analg 2004;98:173-7
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 1996;119:347-54
   PubMed Web of Science ®Google Scholar
• Schwarz J, Meyer R. Nociceptors and pain: correlation of electrophysiology in animals to pain perception in humans. In: Pappagallo M. editor. The Neurological Basis of Pain. McGraw-Hill; New York; 2005. p. 21-9
   Google Scholar
• Klede M, Handwerker HO, Schmelz M. Central origin of secondary mechanical hyperalgesia. J Neurophysiol 2003;90:353-9
   PubMed Web of Science ®Google Scholar
• Klein T, Magerl W, Rolke R, Treede RD. Human surrogate models of neuropathic pain. Pain 2005;115:227-33
   PubMed Web of Science ®Google Scholar
• Koppert W, Zeck S, Blunk JA, The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction. Anesth Analg 1999;89:1521-7
   PubMed Web of Science ®Google Scholar
• Magerl W, Fuchs PN, Meyer RA, Treede RD. Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 2001;124:1754-64
   PubMed Web of Science ®Google Scholar
• Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: normative data and repeatability. Pain 1995;60:329-32
   PubMed Web of Science ®Google Scholar
• Lam VY, Wallace M, Schulteis G. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial. J Pain 2011;12:323-30
   PubMed Web of Science ®Google Scholar
• Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain 1999;122:2245-57
   PubMed Web of Science ®Google Scholar
• Leffler A, Fischer MJ, Rehner D, The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest 2008;118:763-76
   PubMed Web of Science ®Google Scholar